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Greater Los Angeles Healthcare System, Los Angeles, CA, USAA B S T R A C TObjective: To estimate the cost and health outcomes associated with a
new HIV testing strategy that utilizes routine-based clinical reminders.
Methods: We conducted an economic analysis of 1) traditional pretest/
post-test counseling; 2) counseling and a new clinical reminders
system; and 3) only clinical reminder in the veterans’ health care
system. A payer-perspective decision model was conducted to calculate
the 1-year budget impact of three HIV testing strategies. Parameter
values were obtained from the literature, including patients’ probability
of accepting test, and costs associated with HIV testing procedures.
Deidentiﬁed patient data, including total population screened and
number of new HIV cases, were collected from one clinic in Los
Angeles, California, from August 2004 to December 2011. Annual total
costs and costs per new case were calculated on the basis of parameter
values and patient data. Sensitivity analyses were conducted to
evaluate the robustness of the critical variable on costs. Results: Theee front matter Copyright & 2014, International S
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enue, Boston, MA 02215.total cost of the clinical reminder system with pretest counseling
was $81,726 over 1 year compared with $109,208 for traditional HIV
testing. Under a clinical reminder system with no pretest counseling,
the number of HIV tests performed and the number of new diag-
noses increased for that year. In addition, cost per new diagnoses
was the lowest. Conclusions: The clinical reminder system can
reduce the cost per cases identiﬁed and promote better performance
of HIV testing compared with traditional HIV testing. The funda-
mental decision model can be used for hospital facilities outside the
Veteran Affairs adopting a similar program for improving the HIV
testing rate.
Keywords: AIDS, cost analysis, Veterans Affairs Healthcare System.
Copyright & 2014, International Society for Pharmacoeconomics and
Outcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Early identiﬁcation of HIV infection provides clinical beneﬁt to
the infected individuals and reduces the risk of disease trans-
mission. The Centers for Disease Control and Prevention esti-
mates that approximately 19% of the US population is unaware of
its HIV status. This gap has led the Centers for Disease Control
and Prevention, the American College of Physicians, and US
Preventive Services Task Force to recommend that routine,
voluntary HIV testing be offered to adults [1–3]. In response, as
the single largest health care system in the United States, the
Veteran Health Administration (VHA) has implemented a series
of programs to increase early identiﬁcation by promoting HIV
testing [4].
Over time, in responses to changes in the regulatory environ-
ment (i.e., removal of requirements for written informed consent)
and modiﬁcations of recommendations as to who should be
offered HIV testing (i.e., transition from risk-based to routine
testing), different interventions have been undertaken in VHA toimprove HIV testing rates. Although these programs have been
successful as indicated in our previous study, the total costs of
these programs and the cost per identiﬁed case are incompletely
described [5].
This study performed the cost analysis for three alternative
strategies for HIV testing: 1) physician-based traditional HIV
testing and counseling in the absence of clinical reminders; 2)
clinical reminders and nurse-based streamlined counseling with
telephone notiﬁcations for negative results; and 3) clinical
reminders without pretest counseling and with telephone notiﬁ-
cations for negative results. To assist programs that may be
interested in adopting a similar strategy but are uncertain of the
cost implication, we have evaluated the cost per test and the cost
for identifying a previously undiagnosed case of HIV infection.
Because this article focused on evaluating the immediate cost
implication of these new strategies, we did not include the long-
term cost-effectiveness of HIV testing. These analyses will con-
sider the effects of diagnosis and treatment on quality-adjusted
life-year, which is beyond the scope of this study.ociety for Pharmacoeconomics and Outcomes Research (ISPOR).
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Background
When written informed consent was required for HIV testing, nurse-
initiated, streamlined counseling was found to be cost-effective in
increasing HIV testing rates in primary care settings [6]. In August
2005, Goetz et al. [5] used this strategy as part of a multimodal
intervention that included a real-time clinical reminder to prompt
providers to offer risk-based HIV testing, provider education, and an
audit-feedback program to increase HIV testing rates in VHA
medical care facilities in Southern California. The clinical reminder
was triggered by any previous evidence of hepatitis B or C infection,
illicit drug use, a sexually transmitted disease, homelessness, and
certain behavioral risk factors in the patient’s medical record.
Implementation of this program tripled the screening rate and led
to more HIV diagnoses [5]. In August 2009, the VHA policy for HIV
testing was changed. The revised policy removed requirements for
formal pretest and post-test counseling. Meanwhile, verbal consent
was substituted for written consent for testing and testing was
recommended for all persons regardless of known risk of HIV
infection [4]. Following this change, many Veterans Affairs (VA)
facilities changed their policies to be consistent with new VA
requirements and implemented a non–risk-based clinical reminder
to promote HIV testing. Both the original risk-based interventions
and the subsequent modiﬁcation to offer HIV testing to allStrategy A
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testing rates [5,7].Hypothesis and Study Design
This study intended to test the hypothesis that the implementa-
tion of a non–risk-based clinical reminder system for promoting
HIV testing is more cost-effective than traditional risk-based
counseling. The study tested this hypothesis by estimating the
comparative costs of HIV testing strategies in three different
scenarios (Fig. 1):1.sel
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Table 1 – Input variables and sources.
Variable Base Case Range Source
HIV test characteristics,%
Sensitivity of screening test 99.5 60-100 Sanders, 2010 [6]*
Speciﬁcity of entire sequence of testing 99.9994 60-100 Sanders, 2010 [6]
Prevalence of undiagnosed HIV, % 0.4 0.24-0.56 Sanders, 2010 [6]
Probability of accepting test,%
Strategy 1 40 24-56 Sanders, 2010 [6]
Strategy 2 80 48-100 Sanders, 2010 [6]
Strategy 3 90 36-100 Farnham, 2008 [13]
Probability of receiving negative result, %
Strategy 1 33 25-41 Sanders, 2010 [6]; Farnham, 2008 [13]
Strategy 2, 3 75 56-94 Spielberg, 2005 [14]
Probability of receiving positive result, %
Strategy 1, 2, 3 70 53-88 Farnham, Sanders, 2010, [6]
Costs, $
General practitioner wage per hour $85.26 $64-107 Bureau of Labor Statistics [11]
Registered nurse wage per hour $33.23 $25-42 Bureau of Labor Statistics [11]
Clinical reminder (Strategy 2) $0.55 $0.41-0.69 Based on 1 min for nurse to see and resolve
Clinical reminder (Strategy 3) $1.42 $1-2 Based on 1 min for physician to see and resolve
Costs, $
General practitioner wage per hour $85.26 $64-107 Bureau of Labor Statistics [11]
Registered nurse wage per hour $33.23 $25-42 Bureau of Labor Statistics [11]
Clinical reminder (CR)
Physician sees and resolves CR (Strategy 3) $0.71 $0.5-0.89 Based on 30 seconds for physician
Nurse sees and resolves CR (Strategy 2) $0.28 $0.21-0.35 Based on 30 seconds for nurse
Pre-test counseling
Conventional counseling (Strategy 1) $21.32 $21-36 Based on 15 min for physician
Stream-lined counseling (Strategy 2) $3.88 $3-5 Based on 7 min for nurse (Anaya, 2008) [8]
Electronically ordering HIV test
Physician orders test (Strategy 1,3) $0.71 $0.5-0.89 Based on 30 seconds for physician
Nurse orders test (Strategy 2) $0.28 $0.21-0.35 Based on 30 seconds for nurse
Initial negative test $13.46 $10-17 Sanders, 2010 [6]
Conﬁrm positive test $56.27 $42-70 Sanders, 2010 [6]
Post-test counseling for negative result
Strategy 1 $21.32 $16-27 Based on 15 min for physician seen in person
Strategy 2 $2.77 $2-3.50 Based on 5 min for nurse via phone
Strategy 3 $7.11 $5-9 Based on 5 min for physician via phone
Post-test counseling for positive result
Strategy 1 $42.63 $32-53 Based on 30 min for physician
Strategy 2 $16.62 $12-21 Based on 30 min for nurse
Strategy 3 (recommended only) $42.63 $32-53 Based on 30 min for physician
* Strategies A, B and C in this paper respectively correspond to Strategy 1, 2 and 3 in Sander papers.
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personnel involved in the implementation of HIV testing and
excluded the costs of caring for persons found to be HIV-infected
[8]. Figure 1 is a ﬂowchart for each strategy’s procedure, with the
major differences among each circled. We calculated costs and
beneﬁts from the perspective of a VHA health care facility. First,
we identiﬁed the costs per patient associated with each strategy’s
protocol by identifying relevant cost factors from the literature.
Next, we built a decision tree model on TreeAge Pro 2011 using
these differing cost factors and probabilities of test acceptance
and notiﬁcation rates under each strategy. Table 1 lists the base-
case value and the range of each variable entered into it. Using
the computer software for decision tree analysis, Treeage, we
performed a sensitivity analysis on the costs and probabilities in
the model to account for assumptions and to test their effect on
the ﬁndings derived from the model. Last, we estimated 1-year’s
overall costs of each strategy, which was dependent on the
number of people tested and the number of tested people
identiﬁed as being (cases) or not being (noncases) HIV-infected.Strategies B and C included the one-time cost of installing the
clinical reminders and the cost of quarterly feedback reports. The
time horizon of our study was 1 year, and the costs calculated
were converted to 2011 dollars [9].HIV Testing and Receipt of Results
Different procedural requirements for each strategy affected the
costs generated for each patient tested. Using publicly available
databases from the Bureau of Labor Statistics (BLS) and the Health
Economics Resources Center, to estimate direct costs per patient
associated with each testing strategy’s procedure, we ascertained
baseline conditions (conditions before August 2005 in the VA) and
the condition of each intervention’s change (conditions from August
2005 to July 2009 for strategy B, which included both the clinical
reminder system and counseling, and unpublished data collected
during the year 2011 for strategy C, which included only the clinical
reminder system without counseling) (M.B. Goetz, unpublished
V A L U E I N H E A L T H 1 7 ( 2 0 1 4 ) 3 3 4 – 3 3 9 337data, 2012) [5,10]. When published literature was unavailable, we
relied on expert opinion from the senior author (M.B.G.) who has
more than 25 years of experience in developing programs to provide
HIV care within the VHA.
Patient Costs Per Strategy
The time for counseling was multiplied by the median hourly
wage listed on the US BLS Web site for the occupations of “Family
and General Practitioners” and “Registered Nurses” [11]. In strat-
egy A, traditional time for in-person pretest counseling typically
took about 15 minutes [12]. We assumed that the time for in-
person post-test counseling for persons with positive results was
30 minutes of physician time whereas the time for in-person
post-test counseling for persons with negative results was
15 minutes. In strategy B, streamlined pretest counseling typi-
cally took about 7 minutes of nurse time [12]. We assumed that
telephonic test notiﬁcation and post-test counseling of persons
with negative test results took about 5 minutes of nurse time,
whereas it also took nurses 30 minutes to conduct post-test
counseling for persons with positive results. Pretest counseling
was removed in strategy C. Post-test counseling was also no
longer required in strategy C for persons with negative test
results but is still strongly recommended for persons with
positive test results (cases); we estimated that this cost about
30 minutes of the physician time whereas it took the physician
5 minutes to call and report negative test results. Here, Table 1
highlights the base variables with a range of 40% of their base-
case values. All the strategies accounted for an estimated 30
seconds of labor time for the nurse or physician to electronically
order an HIV test for the patient. For each strategy, the initial HIV
test performed (enzyme-linked immunosorbent assay) cost
$13.46. The cost of testing for positive results was $56.27 to
account for the performance of a Western blot test analysis.Clinical Reminder System
Installation and Training Cost
We estimated that it took nurses with technical computer skills,
referred to as “Clinical Applications Coordinators,” about 4 hours
to install the previously developed clinical reminder system at a
VA facility and 20 hours to ensure that all data links were correct.
The BLS wage data for registered nurses were used to calculate
the labor time for the clinical applications coordinator [11].
Audit Feedback and Provider Activation System
The multimodal program also includes an audit feedback and
provider activation component. For the provider activation
aspect, the provider is given education materials for free; how-
ever, we accounted for the cost associated with the time spent by
the clinical champion in promoting the clinical reminder pro-
gram. On the basis of information obtained during previous
studies [5,7], we estimated that 2 hours per month would be
spent during the ﬁrst 6 months of implementation.Analytic Methods
The cost of each strategy is highly dependent on the number of
patients who undergo each testing strategy. The costs associated
with each strategy testing protocol recur for each patient tested.
In addition, costs are higher for cases than for noncases because
multiple screening tests are performed to conﬁrm the positive
result and more provider time is spent with the patient. There-
fore, the probability of patients accepting the test has a hugeimpact on the short-term costs generated in a year. Thus, a
decision tree model was constructed to analyze each HIV testing
strategy’s testing procedure by calculating the cost per case and
noncase of each strategy.
Overall Annual Estimates of Each Strategy
We used the costs for each step in Figure 1 to perform basic
calculations to estimate each strategy’s overall 1-year costs.
Separate calculations were done for persons newly diagnosed
with HIV infection to capture the increased post-test counseling
time spent with these individuals. Because both strategies B and
C utilized the clinical reminder intervention, costs for these
strategies included the one-time installation and feedback costs
associated.
Cost-Effectiveness Analysis of HIV Testing Strategies
The cost-effectiveness of different HIV testing strategies was
compared by calculating the incremental annual total cost per case
as well as per noncase. If strategy B was less costly than strategy C
per case/noncase, then it would be considered cost-effective.
Sensitivity Analysis
The Tree Age model analyzing per-patient costs throughout the
HIV testing process was also used to assess which variables have
the largest effect on the incremental cost-effectiveness ratio
results by performing deterministic, one-way sensitivity analy-
ses. Cost variables of interest were the varying costs of pretest
and post-test counseling. Probabilistic variables of interest were
test acceptance rates and return rates. Calculations were also
performed to determine what number of cases identiﬁed and
what number of noncases identiﬁed would make the total cost of
the most cost-effective strategy equivalent to the total cost of the
next best alternative. All work was approved by the appropriate
institutional review boards.Results
All outcomes are from a single site (strategy A) that has been
previously described [5]. Implementing the clinical reminder system
and streamlining the counseling procedure increased the number
of people tested, the number of cases identiﬁed for that year, and
the number of asymptomatic patients identiﬁed. For strategy A,
1906 patients were tested and 12 new cases of HIV infection were
identiﬁed [5]. For strategy B, when both the clinical reminder system
and counseling were used, 3858 patients were tested and of those
19 new cases were identiﬁed [10]. And ﬁnally, in the absence of
pretesting counseling and the use of only the clinical reminder,
16,172 tests were performed, which resulted in 17 new diagnoses.
All results are from differing 12-month periods of time.
In the presence of clinical reminders for routine testing and
no pretest counseling (strategy C), patients visiting the hospital
were eight times more likely to undergo an HIV test compared
with the period when testing was recommended only for patients
at known risk of infection, pretest counseling, which took 15
minutes, was required, and providers were not prompted by the
clinical reminder to offer HIV testing (strategy A). In addition to
the improved HIV testing, it is important to identify the patient
with HIV earlier before the immune system is impaired by HIV.
When patients were identiﬁed by clinical reminders and pretest/
post-test counseling (strategy B), almost half the cases identiﬁed
were found to have a CD4 count of more than than 200 cells/ml
compared with a third of the patients identiﬁed primarily with
pretest/post-test counseling in the absence of a clinical reminder
(strategy A). Removing pretest/post-test counseling and
Table 2 – Annual costs for each HIV testing strategy.
Strategy A Strategy B Strategy C Strategy B-
Strategy C
Population screened* 1,906 3,858 16,172 12,314
New diagnoses* 12 19 17
Cases identiﬁed with CD44200† 3 9 14
HIV testing costs (recurring costs per patient) $109,031.25 $79,719.01 $241,383.30 $161,664.29
Estimated cost per case $120.93 $77.32 $57.69 $19.62
Estimated Cost per Non-Case $56.80 $20.38 $14.88 $5.50
Implementation of clinical reminder costs (one-time initial costs) ‡ $797.52 $797.52
Clinical applications coordinator installs CR $132.92 $132.92
Clinical applications coordinator troubleshooting CR $664.60 $664.60
Social marketing costs (recurring costs per year)§ $1,210.03 $1,383.47 $173.43
1 Staff member (PhD) requests reminder reports $16.67 $16.67
1 Staff member (BA) generates reports $53.33 $53.33
1 Staff member (BA) disseminates reports $66.67 $66.67
3 Manager reads e-mailed report $110.00 $110.00
15 Physicians read e-mailed report $852.60
5 Nurses read e-mailed report $110.77
20 Physicians read e-mailed report $1,136.80
Estimated annual total cost $109,208.98 $81,726.57 $243,564.29 $161,837.72
* Data was extracted from Goetz et al. [5].
† Data was extracted from Goetz, M.B., Unpublished data on HIV baseline conditions (number of HIV tests and diagnoses) in 2011. 2012
‡ Installation of CR was estimated to cost 4 hours of RN time. Troubleshooting of CR was estimated to cost 20 hours or RN time. RN hourly
wage is $33.23
§ Requesting reminder reports was estimated to cost 1 staff member 5 minutes. Generating reports was estimated to cost 1 staff member 40
minutes. Disseminating reports was estimated to cost 1 staff member 50 minutes. The average time for 1 manger to read emailed reports
was 10 minutes, for 1 physician was 10 minutes, and for one nurse was 10 minutes. Physician’s hourly wage is $85.26. Manager’s hourly wage
is $55. Bachelor’s hourly wage is $20 whereas PhD’s hourly wage is $50.
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resulted in identifying 82% more asymptomatic patients who
had more than 200 CD4 cells/ml. The different strategies have a
signiﬁcant effect on cost and clinical outcomes.
Annual total costs for three HIV testing strategies are presented
in Table 2. Overall, annual costs were strongly inﬂuenced by the
population screened. Strategies B and C included costs related to
implementing the clinical reminder and the provider feedback
operation, while strategy A did not include the intervention costs
but did include the cost of pretest counseling with a physician’s
salary. Strategy B had the lowest annual cost of $81,726, with cost
per test of $21.18. Strategy C had the highest annual cost of
$243,564, with cost per test of $15.06, due to the large population
screened over that time period. Strategy A had the highest cost per
case, $120.93, and cost per noncase, $56.80. Strategy C, which
completely removed the cost of pretest counseling for each patient,
had the lowest cost per case, $57.69, and cost per noncase, $14.88.
Interestingly, even though the cost per test was about two times
more in strategy C than in strategy B, the cost per test was about $6
less per test done in strategy C because there were more individuals
tested in a routine-testing setting.
In addition, Table 2 suggested that under the assumption in
our model, in strategy B the hospital spent $173.43 more per year
in social marketing than under strategy C. In our model, we
examined the effect of health professionals on the ﬁnancial
outcomes. On the basis of expert opinions on the workﬂow at
the clinic, we made a reasonable assumption that 15 physicians
and 5 nurses read reports in strategy B and 20 physicians read
reports in strategy C in our model. Table 2 also presented the
incremental cost per case identiﬁed between strategy B and
strategy C. Strategy A was immediately excluded because it was
found to be “Strongly Dominated,” meaning that strategy A is more
costly and less effective than strategy B. Note that this strategy
does not include the implementation of clinical reminders. Thus,only strategies B and C are compared with cost-effectiveness.
Given the same effectiveness, identiﬁed as one case identiﬁed,
strategy B spent $19.62 less than did strategy C.
One-way sensitivity analysis was performed on variables
associated with recurring patient costs. Using TreeAge, plots were
created using the variable range as the x-axis and the resulting
incremental cost-effectiveness ratio as the y-axis. Variables that
the model was sensitive to were patient acceptance rates at each
strategy and the costs of post-test counseling for noncases during
strategies B and C. Strategies A and B had similar incremental
cost-effectiveness ratios when the probability of accepting a test
during strategy A was 0.33 and when the probability of accepting a
test during strategy B was 0.9. The incremental cost-effectiveness
ratios for strategies A and B were approximately equal when post-
test counseling for negatives cost $7.50. The model was also found
to be sensitive to the cost of pretest counseling during strategy A
when they were at $15.20 and $20.40 at strategy B and strategy C,
respectively. In addition to the cost-effectiveness of strategy C,
the advantage of using strategy C is that more patients are tested
and thus more diagnoses are made.Discussion
We performed the comparative cost analysis of three HIV testing
strategies; two strategies included the ﬁrst-year implementation
costs of clinical reminders, an electronic reminder that helps
facilitate the HIV testing process during a patient’s visit. We
measured short-term costs of these strategies for the ﬁrst year of
implementation of clinical reminders. The implementation of the
clinical reminders is a one-time cost that would not be added in
additional years of using this strategy. Main health outcomes
measured in our model were total annual cost, cost/case identi-
ﬁed, and incremental cost per case or cost per test.
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nurses for physician signiﬁcantly cut annual costs for strategy B
than for strategy A, even with the addition of clinical reminders
and testing costs for the additional patients tested. We found that
at the test level, strategy B and strategy C were less expensive
than strategy A. These two strategies also relatively resulted in
more cases identiﬁed and more cases identiﬁed with higher CD4
counts than with strategy A.
The Centers for Disease Control and Prevention, the American
College of Physicians, and the US Preventive Services Task Force
recommend routine HIV screening in all health care settings
[1–3]. Although strategies B and C both use clinical reminders,
strategy C incorporates routine rather than risk-based HIV test-
ing. Our results suggested that reducing the time spent on
counseling reduced cost per case identiﬁed. To screen one HIV
positive case, strategy C spent $19.62 less in HIV testing than did
strategy B. Our ﬁnding also suggested that the number of cases
identiﬁed increased in strategy C than in strategy B. Therefore,
the total HIV testing costs for strategy C were higher than for
strategy B. Despite the possibility of higher total costs of HIV
testing, the results of strategy C will still facilitate hospital
manager’s decision to implement clinical reminders as the
routine procedure for HIV testing because it will promote the
performance of HIV testing by increasing the number of patients
tested in the long run.
Social marketing cost consists of providers generating,
requesting, reading, and disseminating the clinical reminder
report. Our study found that annual social marketing costs were
$173.43 higher in strategy C than that in strategy B. The social
marketing cost does not affect the costs per test; on the other
hand, it is the changes in policies due to social marketing that
change the cost. Therefore, social marketing increases the total
cost by increasing the numbers of tests that are performed.
Our study has several limitations. Costs were also calculated
under the assumption that the provider already has an electronic
medical records system in place. Data were collected from
patients of a veteran hospital who may have different character-
istics than do non-VA patient populations. Another limitation is
that strategies A, B, and C were introduced sequentially at
different times and that as a consequence the population being
offered HIV testing differed; that is, the highest risk patients were
subject to being offered HIV testing before the implementation of
strategy C, which might then partially explain the lower rates of
new case ﬁnding when strategy C was used. Also, the actual
hourly wages of physicians and nurses in VA hospitals may not
be the same as extracted from the BLS database, the HIV
prevalence rate in VA hospital areas in this study may be quite
different from that in other areas, or physician and nurse time for
counseling may vary across hospitals. Although this analysis was
limited to a single year of results, it is unlikely that per test costs
would change substantially in subsequent years because we
included the initial costs of installing the clinical reminder
software and more than 90% of all costs were directly related to
HIV testing per se. In addition to factors affecting cost, health
managers may need to be mindful of possible barriers early on so
that they can strategize or minimize any delay in adoption,
activation, and installation of clinical reminders. For example,
acquiring additional resources and reserving time are required to
educate coordinators on the expected performance of the clinical
reminder so that they can identify errors in adapting the program
to the speciﬁc data structure of a particular medical facility (e.g.,
differences in laboratory names require customization of the
program to identify persons who have previously undergone HIV
testing). Furthermore, identifying key stakeholders who can serve
as the “local champion” to conduct social marketing and aca-
demic detailing has been proven to be a critical component of thesuccess of programs promoting HIV testing and the use of the
HIV testing clinical reminder within the VA [7,11].
The modeling and economic analysis model provides a useful
tool for decision makers considering new policy, recommenda-
tions, or programs under different scenarios. As illustrated in our
model and assumptions, we projected the cost of 1-year budget of
the three scenarios of HIV testing strategies. In 2012, our research
group showed the marginal effect of the cost on the basis of the
budget impact analysis of improving HIV testing rates, HIV
positive rates, and counseling time in hypothetical scenarios
[8]. As a follow-up to our study, using deidentiﬁed patient data,
here we focused on the budget impact analysis of improving the
HIV testing rate in one hospital facility in Greater Los Angeles,
California. Most recently, because the Affordable Care Act
encourages consumers to use preventive services such as HIV
screening, this could further help increase the HIV testing rate by
removing an economic barrier. It is likely, however, that HIV
testing rates will remain far below the desired rates with the use
of programs such as we have developed to promote and facilitate
HIV testing. In particular, clinical reminders could be an efﬁcient
tool to streamline check-up and screening services; and thus,
physicians can use the time to focus on patient-centered issues
related to specialty services.
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